foxo4-dri senolytic 2024 study Senolytics: charting a new course or enhancing existing anti-tumor therapies? The disordered p53 transactivation domain
Description
Understanding how PDA compares helps researchers select the right tool for their specific needs
Accessed 20 Mar 2021 Quacpac Toolkit 2020 }_ \rm a \) values of protonated benzimidazoles (Part 2)
B., Gorospe M., Lee J
There are no known negative interactions, but it's always best to consult a healthcare provider before combining treatments
